DPI, BII and EBRD Exit KELIX bio to Mubadala
Development Partners International (DPI), British International Investment (BII), the UK government’s Development Finance Institution, and the European Bank for Reconstruction and Development (EBRD), have sold 100% of the shares in KELIX bio, an emerging markets biopharmaceuticals platform, to Mubadala Investment Company (Mubadala), the Abu Dhabi investor with over $276bn in assets under management.